Switzerland · 
Who invested in TOLREMO therapeutics?
TOLREMO therapeutics's investors include BioMedPartners AG, Altos Ventures, Redalpine and Pierre Fabre Invest. BioMedPartners AG led its latest round.
Switzerland · Series A startup
Who invested in TOLREMO therapeutics
Funding summaryUpdated 26 Oct 2026
$38Mraised across 1 round since 2023, from 2 sources
- Latest round
- Series A, $38MSept 2023
- Led by
- BioMedPartners AG
- Investors
- 4 (1 led)
The rounds
- Sept 2023Series A$38M
Reported by Firms' own news pages and 1 other
Everyone who backed them
BioMedPartners AGVC firm1round, led 1
Altos VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists TOLREMO therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about TOLREMO therapeutics
How much has TOLREMO therapeutics raised?
TOLREMO therapeutics has raised $38M across 1 round since 2023.
When did TOLREMO therapeutics last raise?
TOLREMO therapeutics's most recent round was a Series A of $38M in Sept 2023, led by BioMedPartners AG.
What was TOLREMO therapeutics's biggest round?
Its most recent round, $38M in Sept 2023, is also its largest on record.
Who backed TOLREMO therapeutics first?
TOLREMO therapeutics's first round on record, in Sept 2023, was backed by BioMedPartners AG, Altos Ventures and Redalpine and 1 others.
What stage is TOLREMO therapeutics at?
TOLREMO therapeutics's latest named round is a Series A, in Sept 2023.
Where is TOLREMO therapeutics based?
TOLREMO therapeutics is based in Switzerland.
Who led TOLREMO therapeutics's rounds?
BioMedPartners AG led the Series A in 2023.
Companies like TOLREMO therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.